Royal Bank of Canada
LIMN

Royal Bank of Canada’s Liminatus Pharma, Inc. Class A Common Stock LIMN Stock Holding History

Royal Bank of Canada’s Portfolio LIMN Stock Details LIMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$32K Buy
+2,886
New +$32K ﹤0.01% 5734